2-Ethyl-5,6-dimethoxy-3-methyl-benzene-1,4-diol | 91353-18-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 2-Ethyl-5,6-dimethoxy-3-methyl-benzene-1,4-diol
• 英文别名: 2-Ethyl-5,6-dimethoxy-3-methylbenzene-1,4-diol
• CAS: 91353-18-3
• 化学式: C₁₁H₁₆O₄
• 分子量: 212.246
• InChiKey: AWYIASKELIFKHC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  58.9
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• COCRYSTALS OF UBIQUINOL AND COMPOSITIONS COMPRISING THEM
  申请人：Center for Intelligent Research in Crystal Engineering, S.L.

  公开号：US20200385327A1

  公开（公告）日：2020-12-10

  The present invention relates to a cocrystal of ubiquinol and a hydrogen bond donor coformer, to a process for the preparation thereof, and to its use as a medicament or a dietary supplement. The invention also relates to compositions comprising the cocrystal.
• Compositions comprising Quinone and/or Quinol and methods of preparations and use thereof
  申请人：American River Nutrition, LLC

  公开号：US20220409553A1

  公开（公告）日：2022-12-29

  The present embodiments are directed to compositions of quinones and/or quinols, such as, but not limited to, ubiquinone and/or ubiquinol, vitamin E quinone and/or vitamin E quinol, vitamin K quinone and/or vitamin K quinol, menaquinones and/or menaquinols, and pyrroloquinoline quinone and/or pyrroloquinoline quinol, and methods for preparations and use thereof. The present embodiments are also directed to compositions of reduced forms of curcuminoid and methods for preparations and use thereof.
• US9926580B2
  申请人：——

  公开号：US9926580B2

  公开（公告）日：2018-03-27
• [EN] TREATING ARRHYTHMIA WITH MITOCHONDRIAL-TARGETED ANTIOXIDANTS<br/>[FR] TRAITEMENT DE L'ARYTHMIE PAR ANTIOXYDANTS À CIBLAGE MITOCHONDRIAL
  申请人：RHODEL ISLAND HOSPITAL

  公开号：WO2016007921A1

  公开（公告）日：2016-01-14

  This invention relates to reducing the risk of arrhythmias as a result of an acute cardiovascular disorder or injury such as a myocardial infarction by using mitochondrial- targeted antioxidants to improve cardiac function.